author-photo

Sherri Z. Millis

Foundation Medicine

121

Papers

1232

Citations

Citation Trend

Filter By

Papers (89) Sort By

Journal Conference Others

Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach.

2021 Journal of Investigative Dermatology
Show All
- Source
- Cite
- Save
Citations (5)
Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (0)
710P Comprehensive genomic profiling (CGP) of small cell neuroendocrine carcinoma of the bladder (NEBC)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large-Scale Data to Inform Therapeutic Directions.

2020 Oncologist
Show All
- Source
- Cite
- Save
Citations (3)
Recurrent secondary genomic alterations in desmoplastic small round cell tumors.

2020 BMC Medical Genetics
Show All
- Source
- Cite
- Save
Citations (4)
Landscape of cyclin pathway genomic alterations across 7,207 non-prostate genitourinary tumors.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Cyclin pathway genomic alterations across 5,356 prostate cancers.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Multiscale omic assessment of EWSR1-NFATc2 fusion positive sarcomas to identify conserved fusion breakpoint and activation of the mTOR pathway.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma

2019 Oncotarget
Show All
- Source
- Cite
- Save
Citations (52)